Health News Releases

  • Today April 21
August 01, 2023 16:24
First half of 2023: Boehringer Ingelheim sees strong growth and expansion in key therapy areas
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, continues to advance its pipeline in both Human Pharma and Animal Health expanding across its key therapy areas. Currency-
Ferrer's 2022 Sustainability Report front page (Photo: Ferrer)
July 30, 2023 14:30
Ferrer Allocates, on Average, More Than 40% of its Profits to Social and Environmental Projects for the Third Consecutive Year
The pharmaceutical company Ferrer, certified as a B Corp in 2022, has again shown that there is another way of doing business, with an ethical business approach that contributes to a better society. O
July 30, 2023 13:45
Mouser Electronics Shares the Revolutionary Power of Digital Therapeutics in Latest Empowering Innovation Together Series
Mouser Electronics Inc., the industry's leading New Product Introduction (NPI) distributor with the widest selection of semiconductors and electronic components™, premieres its latest installment of t
July 30, 2023 11:30
Takeda Reports Strong First Quarter FY2023 Results, Driven by Growth & Launch Products
Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for the first quarter of fiscal year 2023 (period ended June 30, 2023). Takeda chief financial officer, Costa Saroukos, comment
July 28, 2023 09:25
Medisca Expands Strategic Partnerships to Drive Patient Access to Critical Medications
Medisca has announced the expansion of a network of strategic partnerships aimed at securing and stabilizing worldwide access to high quality active pharmaceutical ingredients (APIs) for the preparati
July 27, 2023 14:16
Galderma Achieves Record 2 B USD Net Sales for a Six-Month Period in H1 2023, as It Continues to Demonstrate Leading Execution and Innovation Capabilities in Dermatology
Galderma: · Galderma maintained strong momentum across all product categories reaching 2,003 M USD net sales in H1 2023, up 6.9% year-on-year on a constant currency basis · Growth primarily driven
July 27, 2023 10:35
The New England Journal of Medicine Publishes Data from Phase 2 Study of First Oral Orexin Receptor 2 Agonist TAK-994 in Patients with Narcolepsy Type 1
Takeda (TSE:4502/NYSE:TAK) today announced that data from the Phase 2 study of orexin receptor 2 (OX2R) agonist TAK-994 in patients with narcolepsy type 1 (NT1) was published in The New England Journa
July 27, 2023 10:00
AmbioPharm, a Global Peptide CDMO
AmbioPharm, a worldwide leader in peptide API CDMO services, continues growth to meet capacity demands for late phase and commercial peptide production. A reliable peptide CDMO with manufacturing faci
July 26, 2023 17:35
Aleph Farms Submits First Ever Application for Cultivated Meat in Europe
Aleph Farms, a cellular agriculture company that enhances sustainability, food security and animal welfare in our food systems, today announced that it has submitted an application for regulatory appr
July 26, 2023 17:15
BaroPace Receives Approval for First-in-Human Clinical Trial
BaroPace, Inc., a medical technology company dedicated to using blood pressure to regulate pacemakers for patients with heart failure with preserved ejection fraction and hypertension, announced today
July 26, 2023 10:45
Jardiance® (empagliflozin) approved in the EU for the treatment of adults with chronic kidney disease
The European Commission (EC) approved Jardiance® (empagliflozin) for the treatment of adults with chronic kidney disease (CKD),[8] Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced
July 25, 2023 11:30
Kenvue To File Form S-4 Registration Statement in Connection with Johnson & Johnson Exchange Offer Announcement
Kenvue Inc. (NYSE: KVUE) (“Kenvue”) announced that it intends to file a Form S-4 Registration Statement today with the Securities and Exchange Commission (the “SEC”) in connection with Johnson & Johns
July 25, 2023 11:15
Orthogon Therapeutics Celebrates Major Technical Milestone and Secures Additional $6M Toward a Pioneering Drug for BK Virus
Orthogon Therapeutics LLC, a trailblazer in the field of antiviral therapeutics, today announced a dual victory. Orthogon’s lead molecule has successfully completed acute toxicity studies, marking a p
July 21, 2023 11:45
Kenvue Initiates Quarterly Cash Dividend
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced that its Board of Directors has declared a dividend payable in the third quarter
July 17, 2023 09:30
TauRx’s Hydromethylthionine Mesylate (HMTM) Demonstrates Significant Reduction in Neurodegeneration in Alzheimer’s Disease (AD)
TauRx Pharmaceuticals Ltd., a global leader in Tau-based research in Alzheimer’s disease (AD), today announced results from a prespecified analysis of the Phase 3 LUCIDITY trial that measured the impa
(Photo: Wyss Center for Bio and Neuroengineering)
July 11, 2023 10:05
Wyss Center Appoints Dr. Craig Cook as New Head of Business Development and Licensing
The Wyss Center, a leading non-profit research center dedicated to innovating and accelerating technologies and therapies for neurological and mental health disorders, is pleased to announce the appoi
July 07, 2023 09:10
Biocytogen Pharmaceuticals Enters Into License Agreement With Pheon Therapeutics
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody therapeutics, today announces an antibody license agree
Gachon University Gil Medical Center (Gil Medical Center), a pioneering health provider with many “f
July 06, 2023 13:08
Rimini Support™ Enables Gachon University Gil Medical Center to Advance its Digital Transformation Projects and Continue to Serve the Community as a Trailblazer Hospital
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, products and services, the leading third-party support provider for Oracle and SAP software, and a Sale
July 06, 2023 10:15
First Distribution Agreement Executed with Sonic Healthcare
Microba Life Sciences Limited (ASX: MAP) (“Microba”) is pleased to announce that it has executed a commercial agreement with Sonic Healthcare Limited (ASX: SHL) through a wholly owned subsidiary Dougl
GilletteLabs Razor with Exfoliating Bar (Photo: Business Wire)
July 05, 2023 09:30
P&G Grooming Invites Dermatologist Community to Go ‘Skin Deep Into Grooming’ at the 25th World Congress of Dermatology
At this year’s 25th World Congress of Dermatology held in Singapore (July 3rd - 8th), P&G’s Grooming Division will spotlight product solutions routed in 120 years of innovation heritage and scientific
July 04, 2023 17:11
Galderma @ WCD 2023: Late-Breaking Phase III Results for Nemolizumab Monotherapy in Prurigo Nodularis Show a Significant Proportion of Itch-Free Patients by Week 4
Galderma presented the latest data from its pivotal phase III OLYMPIA 2 trial at the 25th World Congress of Dermatology (WCD) in Singapore. The results highlight the rapid onset of action of nemolizum
About Generalized Pustular Psoriasis (Graphic: Business Wire)
July 04, 2023 16:25
Spesolimab prevents generalized pustular psoriasis flares in EFFISAYIL™ 2 trial
Today, at the 25th World Congress of Dermatology (WCD), Boehringer Ingelheim presented new late-breaking data from the EFFISAYIL™ 2 trial showing that spesolimab significantly reduced the risk of GPP
Audience at IMPAHCT (International Meeting on Pulmonary Hypertension Clinical Treatment) organized b
July 04, 2023 10:10
Experts Call for Protocols to Speed up Referrals for Pulmonary Hypertension to Specialized Centers
The IMPAHCT (International Meeting on Pulmonary Hypertension Clinical Treatment) event, organized by the pharmaceutical company Ferrer, has brought together more than 150 pulmonologists and cardiologi
July 04, 2023 09:50
After the Great Success Achieved in the United States and Canada, DEKA Launches Three Extraordinary Laser and Microwave Platforms at the World Congress of Dermatology in Singapore
DEKA, a subsidiary of the El.En. Group, a company listed on the Eurostar Next of the Italian Stock Exchange (ELN.MI), specialized in the development and manufacturing of cutting-edge Energy Based Devi
OncoPro Tumoroid Culture Medium Kit (Photo: Business Wire)
June 29, 2023 14:05
Thermo Fisher Scientific Introduces Tumoroid Culture Medium to Accelerate Development of Novel Cancer Therapies
Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the Gibco™ OncoPro™ Tumoroid Culture Medium Kit*, the first commercially available culture medium specifica
25 per page50 per page75 per page100 per page